A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Severe Steroid Dependent Asthma

Trial Profile

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Severe Steroid Dependent Asthma

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Sep 2017

At a glance

  • Drugs Dupilumab (Primary) ; Prednisolone; Prednisolone; Prednisone; Prednisone
  • Indications Asthma
  • Focus Registrational; Therapeutic Use
  • Acronyms VENTURE
  • Sponsors Sanofi
  • Most Recent Events

    • 11 Sep 2017 According to a Regeneron Pharmaceuticals media release, data from this study is expected later this year.
    • 06 Sep 2017 This trial has been completed in Belgium according to European Clinical Trials Database record
    • 05 Jul 2017 This trial has been completed in spain according to European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top